Skip to content

To Evaluate The Efficacy Of Vidangadi Nasya In Ardhavabhedak W.S.R To Migraine

Randomized Open Controlled Clinical Study To Evaluate The Efficacy Of Vidangadi Nasya In Ardhavabhedak W.S.R To Migraine - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089289
Enrollment
80
Registered
2025-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Sponsors

Dr Dimpal Ravindra Bhadane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting signs and symptoms of ardhavabhedak like attack of headache mostly unilateral in nature variable in intensity frequency and duration with or without nausea Patient will be selected irrespective of gender religion or occupation Patient age between 18 years to 60 years Patient willing to give inform consent and able to participate in study Patient fit for nasya karma

Exclusion criteria

Exclusion criteria: Patient having severe systemic diseases like HTN DM Asthma Women who is under menstrual cycle Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Vidangadi nasya in Ardhavabhedak W.S.R. to migraineTimepoint: 3 months

Secondary

MeasureTime frame
To reduce signs & symptoms of Ardhavabhedak To assess improvement by signs symptoms & gradation of assessment criteria To study etiopathology clinical manifastation of ardhavabhedak To improve quality of life & reduce discomfort of patient Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Vidyanand Thorwat

Yashwant Ayurvedic College Post Graduate Training And Research Centre

vidyanandthorwat@yahoo.com9011081819

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026